Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company.
Our shares are listed on the SIX Swiss Exchange (NWRN).
Our mission is to discover, develop and commercialise novel drugs to treat
diseases of the Central Nervous System (CNS) and pain.
September 30, October 1, 2015 - ConventionPoint, SIX Swiss Exchange, Zürich - Switzerland
September 10, 2014 - Millennium Broadway Hotel - New York City, USA
June 1-4, 2015 - Grand Hyatt, New York - USA